advertisement
Katz LJ 31
Showing records 1 to 25 | Display all abstracts from Katz LJ90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Shalaby WS
Ophthalmology. Glaucoma 2021; 4: 182-192
90058 Beliefs and Attitudes of Ophthalmologists Regarding SLT as First Line Therapy for Glaucoma
Bonafede L
Journal of Glaucoma 2020; 29: 851-856
90772 Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma
Saheb H
Current Eye Research 2020; 0: 1-8
89941 Current and new pharmacotherapeutic approaches for glaucoma
Shalaby WS
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040
90182 iStent inject®: A Comprehensive Survey of the Literature
Shalaby WS
Journal of Cataract and Refractive Surgery 2021; 47: 385-399
89941 Current and new pharmacotherapeutic approaches for glaucoma
Shankar V
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040
90182 iStent inject®: A Comprehensive Survey of the Literature
Jia J
Journal of Cataract and Refractive Surgery 2021; 47: 385-399
90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Myers JS
Ophthalmology. Glaucoma 2021; 4: 182-192
90058 Beliefs and Attitudes of Ophthalmologists Regarding SLT as First Line Therapy for Glaucoma
Sanvicente CT
Journal of Glaucoma 2020; 29: 851-856
90772 Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma
Donnenfeld ED
Current Eye Research 2020; 0: 1-8
90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Razeghinejad R
Ophthalmology. Glaucoma 2021; 4: 182-192
90058 Beliefs and Attitudes of Ophthalmologists Regarding SLT as First Line Therapy for Glaucoma
Hark LA
Journal of Glaucoma 2020; 29: 851-856
89941 Current and new pharmacotherapeutic approaches for glaucoma
Razeghinejad R
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040
90772 Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma
Solomon KD
Current Eye Research 2020; 0: 1-8
90182 iStent inject®: A Comprehensive Survey of the Literature
Katz LJ; Lee D
Journal of Cataract and Refractive Surgery 2021; 47: 385-399
90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Katz LJ
Ophthalmology. Glaucoma 2021; 4: 182-192
89941 Current and new pharmacotherapeutic approaches for glaucoma
Katz LJ
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040
90058 Beliefs and Attitudes of Ophthalmologists Regarding SLT as First Line Therapy for Glaucoma
Tran J
Journal of Glaucoma 2020; 29: 851-856
90772 Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma
Voskanyan L; Chang DF
Current Eye Research 2020; 0: 1-8
90058 Beliefs and Attitudes of Ophthalmologists Regarding SLT as First Line Therapy for Glaucoma
Tran E
Journal of Glaucoma 2020; 29: 851-856
90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Pro M
Ophthalmology. Glaucoma 2021; 4: 182-192
90772 Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma
Samuelson TW
Current Eye Research 2020; 0: 1-8
90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Dale E
Ophthalmology. Glaucoma 2021; 4: 182-192
90058 Beliefs and Attitudes of Ophthalmologists Regarding SLT as First Line Therapy for Glaucoma
Zhang Q
Journal of Glaucoma 2020; 29: 851-856
90772 Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma
Ahmed IIK
Current Eye Research 2020; 0: 1-8
